NCT05354752

Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects

Randomized, Double-blind, Multiple-dose Escalation, Placebo-controlled Phase I Clinical Study to Evaluate the Tolerance, Pharmacokinetics and Pharmacodynamics of VC005 Tablets in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Jiangsu vcare pharmaceutical technology co., LTD · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

This clinical trial is a randomized, double-blind, single-center, placebo-controlled and multiple-dose escalation Pharmacokinetics study

Detailed description

The main purpose of this trial is to evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of VC005 Tablets in healthy subjects.

Conditions

• Inflammatory Bowel Diseases

Interventions

Type	Name	Description
DRUG	VC005 tablets	VC005 groups repeat administration for 7 days
DRUG	VC005 Placebo tablets	VC005 placebo groups repeat administration for 7 days

Timeline

• Start date: 2022-06-18
• Primary completion: 2022-11-02
• Completion: 2022-11-15
• First posted: 2022-04-29
• Last updated: 2022-11-17

Locations

1 site across 1 country: China